References
- Kostrezewa R. M., Jacobowitz D. M. Pharmacological actions of 6-hydroxydopamine. Pharmacology Review 1974; 26: 199–288
- Sachs C., Jonsson G. Mechanisms of action of 6-hydroxydopamine. Biochemical Pharmacology 1975; 24: 1–8
- Graham D. G., Tiffany S. M., Bell W. M., Gutknecht W. F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cell. in vitro. Molecular Pharmacology 1978; 14: 644–653
- Gee P., Davison A. J. Effects of scavengers of oxygen free radicals on the anaerobic oxidation of 6-hydroxydopamine by H2O2. Biochemica et Biophysica Acta 1985; 838: 183–190
- Gee P., Davison A. J. Intermediates in the aerobic autoxidation of 6-hydroxydopamine: Relative importance under different reaction conditions. J. Free. Radic. Biol. Med. 1989; 6: 271–284
- Cohen G., Heikkila R. E. Degeneration of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J. Biol. Chem. 1974; 249: 2447–2452
- Zaizen Y., Nakagawara A., Ikeda K. Patterns of destruction of mouse neuroblastoma cells by extracellular hydrogen peroxide formed by 6-hydroxydopamine and ascorbate. J. Cancer Res. Clin. Oncol. 1986; 111: 93–97
- Reynolds C. P., Reynolds D. A., Frenkel E. P., Smith R. G. Selective toxicity of 6-hyroxydopamine and ascorbate for human neuroblastoma in vitro: A model for clearing marrow prior to autologous transplant. Cancer Research 1982; 42: 1331–1336
- Iancu T. C., Shilo H., Kedar A. Neuroblastomas contain iron-rich ferritin. Cancer 1988; 61: 2497–2502
- Samokyszyn V. M., Thomas C. E., Reif D. W., Saito M., Aust S. D. Release of iron from ferritin and its role in oxygen radical toxicities. Drug Metabolic Review 1988; 19: 283–303
- Monteiro H. P., Vile G. F., Winterbourn C. C. Release of iron from ferritin by semiquinone, anthracycline, bipyridyl, an nitroaromatic radicals. Journal of Free Radicals in Biological Medicine 1989; 6: 587–591
- Biemont P., VanEijk H. G., Swaak A. J.G., Koster J. F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphnuclear leukocytes. Journal of Clinical Investigation 1988; 73: 1576–1579
- Boyer R. F., Grabill T. W., Petrowich R. M. Reductive release of ferritin iron: A kinetic assay. Analytical Biochemistry 1988; 174: 17–22
- Stookey L. L. Ferrozine-A new spectrophotometric reagent for iron. Analytical Chemistry 1970; 42: 779–781
- Heikkila R. E., Cohen G. Prevention of 6-OHDA induced neurotoxicity. Chemical tools in catecholamine research, Vol. 1, G. Jonsson, T. Malmfors, C. Sachs. North-Holland Publishing Company. 1975; 7–14
- Monteiro H. P., Winterbourn C. C. The superoxide-dependent transfer of iron from ferritin to transferrin and lactoferrin. Biochemical Journal 1988; 256: 923–928
- Koster J. F., Slee R. G. Ferritin, a physiological iron donor for microsomal lipid peroxidation. FEBS Lett. 1986; 199: 85–88
- Reif D. W., Schubert F., Aust S. D. Iron release from ferritin and lipid peroxidation by radiolytically generated reducing radicals. Arch. Biochem. Biophys. 1988; 264: 238–243
- Buck J., Bruchelt G., Girgert R., Treuner J., Niethammer D. Specific uptake of m-[125I] iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Research 1985; 45: 6366–6370